[1] |
中华医学会外科学分会胃肠外科学组,中华医学会外科学分会结直肠肛门外科学组,中国抗癌协会大肠癌专业委员会, 等. 结直肠癌肝转移诊断和综合治疗指南(2016版)[J]. 中华消化外科杂志, 2016, 15(8):755-767.
|
[2] |
Cutsem EV, Nordlinger B, Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases[J]. Eur J Cancer, 2006, 42(14):2212-2221.
|
[3] |
Scheele J, Altendorf-Hofmann A, Grube T, et al. Resection of colorectal liver metastases: what prognostic factors determine patient selection?[J]. Chirurg, 2001, 72(5):547-560.
|
[4] |
Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial[J]. Lancet Oncol, 2010, 11(1):38-47.
|
[5] |
Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage Ⅳ colorectal cancer receiving combination chemotherapy without surgery as initial treatment[J]. J Clin Oncol, 2009, 27(20):3379-3384.
|
[6] |
杨杨,汪国营. 结直肠癌肝转移的治疗策略[J/CD]. 中华肝脏外科手术学电子杂志, 2015, 4(1):1-5.
|
[7] |
Bonney GK, Coldham C, Adam R, et al. Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; an international multi-center data analysis using LiverMetSurvey[J]. J Surg Oncol, 2015, 111(6):716-724.
|
[8] |
邢宝才,徐达. 结直肠癌肝转移的临床研究进展[J]. 中华肿瘤杂志, 2015, 37(9):659-663.
|
[9] |
戴冬秋,张春东. 不可切除结直肠癌肝转移病人原发灶的处理[J]. 中国实用外科杂志, 2013, 33(8):661-665.
|
[10] |
胡丹旦,万德森. 同时性结直肠癌肝转移的外科治疗策略[J]. 临床肿瘤学志, 2018, 23(12): 1135-1139.
|
[11] |
Wang L, Sun Y, Zhao B, et al. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis[J]. Oncotarget, 2016, 7(34): 55732-55740.
|
[12] |
李斌奎,陈功. 结直肠癌肝转移诊疗新理念与新策略[J]. 中华转移性肿瘤杂志, 2018, 1(3): 52-61.
|
[13] |
Ribeiro HS, Torres OJ, Marques MC, et al. I Brazilian consensus on multimodal treatment of colorectal liver metastases. module 2: approach to resectable metastases[J]. Arq Bras Cir Dig, 2016, 29(1): 9-13.
|
[14] |
刁竞芳,莫嘉强,叶青,等. 经腹腔镜超声引导下微波消融同期治疗结直肠癌肝转移疗效[J/CD].中华肝脏外科手术学电子杂志,2017, 6(4): 312-315.
|
[15] |
Mise Y, Aloia TA, Brudvik KW, et al. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival[J]. Ann Surg, 2016, 263(1):146-152.
|
[16] |
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases[J]. Ann Surg, 2004, 239(6):818-825.
|
[17] |
Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontières meeting 2013[J]. Eur Radiol, 2015, 25(12):3438-3454.
|
[18] |
van Amerongen MJ, van der Stok EP, Fütterer JJ, et al. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation[J]. Eur J Surg Oncol, 2016, 42(4):523-530.
|
[19] |
Chiappa A, Bertani E, Zbar AP, et al. Optimizing treatment of hepatic metastases from colorectal cancer: resection or resection plus ablation?[J]. Int J Oncol, 2016, 48(3):1280-1289.
|
[20] |
Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. a prognostic scoring system to improve case selection, based on 1 568 patients. Association Française de Chirurgie[J]. Cancer, 1996, 77(7):1254-1262.
|
[21] |
Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. analysis of the European organisation for research and treatment of cancer #40004 and #40983[J]. Eur J Cancer, 2014, 50(5):912-919.
|